{"id":"https://openalex.org/W4281663663","doi":"https://doi.org/10.3390/nano12111942","title":"Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study","display_name":"Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study","publication_year":2022,"publication_date":"2022-06-06","ids":{"openalex":"https://openalex.org/W4281663663","doi":"https://doi.org/10.3390/nano12111942","pmid":"https://pubmed.ncbi.nlm.nih.gov/35683795","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9183115"},"language":"en","primary_location":{"id":"doi:10.3390/nano12111942","doi":"https://doi.org/10.3390/nano12111942","is_oa":true,"landing_page_url":"https://doi.org/10.3390/nano12111942","pdf_url":"https://www.mdpi.com/2079-4991/12/11/1942/pdf?version=1654673045","source":{"id":"https://openalex.org/S2764646681","display_name":"Nanomaterials","issn_l":"2079-4991","issn":["2079-4991"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomaterials","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2079-4991/12/11/1942/pdf?version=1654673045","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059924135","display_name":"Subhra Mandal","orcid":"https://orcid.org/0000-0003-0047-4305","observed_orcids":["https://orcid.org/0000-0003-0047-4305"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Subhra Mandal","raw_affiliation_strings":["School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA"],"raw_orcid":"https://orcid.org/0000-0003-0047-4305","affiliations":[{"raw_affiliation_string":"School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082755001","display_name":"Shawnalyn W Sunagawa","orcid":"https://orcid.org/0009-0005-3068-3732","observed_orcids":["https://orcid.org/0009-0005-3068-3732"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawnalyn W. Sunagawa","raw_affiliation_strings":["School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077724384","display_name":"Pavan Kumar Prathipati","orcid":"https://orcid.org/0000-0002-2463-3350","observed_orcids":["https://orcid.org/0000-0002-2463-3350"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pavan Kumar Prathipati","raw_affiliation_strings":["School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007044731","display_name":"Michael Belshan","orcid":"https://orcid.org/0000-0001-5736-9907","observed_orcids":["https://orcid.org/0000-0001-5736-9907"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Belshan","raw_affiliation_strings":["Department of Medical Microbiology & Immunology, Creighton University School of Medicine, Creighton University, Omaha, NE 68178, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Microbiology & Immunology, Creighton University School of Medicine, Creighton University, Omaha, NE 68178, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078053243","display_name":"Annemarie Shibata","orcid":"https://orcid.org/0000-0003-2451-3065","observed_orcids":["https://orcid.org/0000-0003-2451-3065"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annemarie Shibata","raw_affiliation_strings":["Department of Biology, College of Arts and Sciences, Creighton University, Omaha, NE 68178, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, College of Arts and Sciences, Creighton University, Omaha, NE 68178, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031015958","display_name":"Christopher J. Destache","orcid":"https://orcid.org/0000-0001-7923-3939","observed_orcids":["https://orcid.org/0000-0001-7923-3939"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher J. Destache","raw_affiliation_strings":["Division of Infectious Diseases, School of Medicine, Creighton University, Omaha, NE 68178, USA","School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA"],"raw_orcid":"https://orcid.org/0000-0001-7923-3939","affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, School of Medicine, Creighton University, Omaha, NE 68178, USA","institution_ids":["https://openalex.org/I114493937"]},{"raw_affiliation_string":"School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA","institution_ids":["https://openalex.org/I114493937"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5059924135"],"corresponding_institution_ids":["https://openalex.org/I114493937"],"apc_list":{"value":2400,"currency":"CHF","value_usd":2513},"apc_paid":{"value":2400,"currency":"CHF","value_usd":2513},"fwci":0.1251,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.22958008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"12","issue":"11","first_page":"1942","last_page":"1942"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8154000043869019,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8154000043869019,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.10170000046491623,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.04390000179409981,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.7929999828338623},{"id":"https://openalex.org/keywords/ccr5","display_name":"CCR5","score":0.7900000214576721},{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.7310000061988831},{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.8679999709129333},{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8899999856948853},{"id":"https://openalex.org/keywords/pre-exposure-prophylaxis","display_name":"pre-exposure prophylaxis","score":0.9089999794960022},{"id":"https://openalex.org/keywords/hiv-latency","display_name":"HIV latency","score":0.6430000066757202},{"id":"https://openalex.org/keywords/functional-cure","display_name":"functional cure","score":0.8820000290870667},{"id":"https://openalex.org/keywords/t-cell-subsets","display_name":"T cell subsets","score":0.5090000033378601},{"id":"https://openalex.org/keywords/chemokine-receptor-blockade","display_name":"chemokine receptor blockade","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6616927981376648},{"id":"https://openalex.org/C124978682","wikidata":"https://www.wikidata.org/wiki/Q1201019","display_name":"Proof of concept","level":2,"score":0.6132593750953674},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.6011806726455688},{"id":"https://openalex.org/C2777431735","wikidata":"https://www.wikidata.org/wiki/Q1535975","display_name":"Burden of proof","level":2,"score":0.5707377195358276},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.47888845205307007},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.39987343549728394},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3722502589225769},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3081496059894562},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.24484971165657043},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.231779545545578},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.10982534289360046},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.1088876724243164},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/nano12111942","doi":"https://doi.org/10.3390/nano12111942","is_oa":true,"landing_page_url":"https://doi.org/10.3390/nano12111942","pdf_url":"https://www.mdpi.com/2079-4991/12/11/1942/pdf?version=1654673045","source":{"id":"https://openalex.org/S2764646681","display_name":"Nanomaterials","issn_l":"2079-4991","issn":["2079-4991"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomaterials","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9183115","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9183115","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomaterials (Basel)","raw_type":"Text"},{"id":"pmid:35683795","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35683795","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomaterials (Basel, Switzerland)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2123b81dcfc846a2ae7edb0954ff24ed","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/2123b81dcfc846a2ae7edb0954ff24ed","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nanomaterials, Vol 12, Iss 11, p 1942 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/nano12111942","doi":"https://doi.org/10.3390/nano12111942","is_oa":true,"landing_page_url":"https://doi.org/10.3390/nano12111942","pdf_url":"https://www.mdpi.com/2079-4991/12/11/1942/pdf?version=1654673045","source":{"id":"https://openalex.org/S2764646681","display_name":"Nanomaterials","issn_l":"2079-4991","issn":["2079-4991"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomaterials","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8399999737739563}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8204786917","display_name":"Long-acting antiretroviral nanoparticles for HIV prophylaxis","funder_award_id":"R01AI117740","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4281663663.pdf","grobid_xml":"https://content.openalex.org/works/W4281663663.grobid-xml"},"referenced_works_count":68,"referenced_works":["https://openalex.org/W643357394","https://openalex.org/W1414886268","https://openalex.org/W1508502528","https://openalex.org/W1519681534","https://openalex.org/W1592628801","https://openalex.org/W1965540482","https://openalex.org/W1972975232","https://openalex.org/W1974845816","https://openalex.org/W1993331347","https://openalex.org/W1995617158","https://openalex.org/W1998310721","https://openalex.org/W2001433846","https://openalex.org/W2003848040","https://openalex.org/W2017552802","https://openalex.org/W2054152236","https://openalex.org/W2055973102","https://openalex.org/W2060076563","https://openalex.org/W2075052852","https://openalex.org/W2075144974","https://openalex.org/W2076965602","https://openalex.org/W2080966262","https://openalex.org/W2086201314","https://openalex.org/W2091473990","https://openalex.org/W2103728277","https://openalex.org/W2108260141","https://openalex.org/W2126255146","https://openalex.org/W2146443631","https://openalex.org/W2146933058","https://openalex.org/W2147169218","https://openalex.org/W2151715557","https://openalex.org/W2151889813","https://openalex.org/W2161243054","https://openalex.org/W2166332777","https://openalex.org/W2186013781","https://openalex.org/W2193135276","https://openalex.org/W2274674158","https://openalex.org/W2305048085","https://openalex.org/W2410886236","https://openalex.org/W2502542881","https://openalex.org/W2512917887","https://openalex.org/W2551108844","https://openalex.org/W2559957105","https://openalex.org/W2563293871","https://openalex.org/W2581908800","https://openalex.org/W2604891032","https://openalex.org/W2619230229","https://openalex.org/W2620136843","https://openalex.org/W2738541296","https://openalex.org/W2738645432","https://openalex.org/W2751654222","https://openalex.org/W2769406337","https://openalex.org/W2777043689","https://openalex.org/W2800208837","https://openalex.org/W2801579480","https://openalex.org/W2805692414","https://openalex.org/W2805966967","https://openalex.org/W2895791887","https://openalex.org/W2905194845","https://openalex.org/W2923877036","https://openalex.org/W2931770039","https://openalex.org/W2954876634","https://openalex.org/W2963596058","https://openalex.org/W2980579677","https://openalex.org/W2981507062","https://openalex.org/W3016344065","https://openalex.org/W4321428366","https://openalex.org/W6671152102","https://openalex.org/W6686656323"],"related_works":["https://openalex.org/W3016527260","https://openalex.org/W2981709071","https://openalex.org/W4406160048","https://openalex.org/W2273558707","https://openalex.org/W2805692414","https://openalex.org/W1985830416","https://openalex.org/W2912268921","https://openalex.org/W7110641538","https://openalex.org/W4317387818","https://openalex.org/W7058320409"],"abstract_inverted_index":{"The":[0,100,170],"C-C":[1],"motif":[2],"chemokine":[3],"receptor-5":[4],"(CCR5)":[5],"expression":[6],"on":[7],"the":[8,12,78,104,139,174],"T-cell":[9],"surface":[10,81],"is":[11],"prime":[13],"barrier":[14],"to":[15,36,70,96,128],"HIV/AIDS":[16],"eradication,":[17],"as":[18],"it":[19],"promotes":[20],"both":[21],"active":[22],"human":[23],"immunodeficiency":[24],"virus":[25],"(HIV)-infection":[26],"and":[27,60,89,118,134,149,166],"latency;":[28],"however,":[29],"antiretrovirals":[30],"(ARVs)":[31],"suppress":[32],"plasma":[33],"viral":[34],"loads":[35],"non-detectable":[37],"levels.":[38],"Keeping":[39],"this":[40],"in":[41],"mind,":[42],"we":[43],"strategically":[44],"designed":[45],"a":[46,66,154,159,181],"targeted":[47,61],"ARVs-loaded":[48],"nanoformulation":[49,79,123,176],"that":[50,103,145,173],"targets":[51],"CCR5":[52,108,129,147],"expressing":[53,130],"T-cells":[54],"(e.g.,":[55],"CD4+":[56,131],"cells).":[57],"Conceptually,":[58],"CCR5-blocking":[59],"ARV":[62,119,150],"delivery":[63],"would":[64],"be":[65],"dual":[67],"protection":[68],"strategy":[69],"prevent":[71],"HIV":[72,98,186],"infection.":[73],"For":[74],"targeting":[75],"CCR5+":[76,136],"T-cells,":[77],"was":[80],"conjugated":[82],"with":[83,91,158],"anti-CCR5":[84],"monoclonal":[85],"antibodies":[86],"(CCR5":[87],"mAb)":[88],"loaded":[90],"dolutegravir+tenofovir":[92],"alafenamide":[93],"(D+T)":[94],"ARVs":[95],"block":[97],"replication.":[99],"result":[101],"demonstrated":[102,124,144],"targeted-ARV":[105,175],"nanoparticle's":[106],"multimeric":[107],"binding":[109,126],"property":[110],"improved":[111],"its":[112],"antigen-binding":[113],"affinity,":[114],"prolonged":[115,146],"receptor":[116],"binding,":[117],"intracellular":[120],"retention.":[121],"Further,":[122],"high":[125],"affinity":[127],"cells,":[132],"monocytes,":[133],"other":[135],"T-cells.":[137],"Finally,":[138],"short-term":[140],"pre-exposure":[141],"prophylaxis":[142],"study":[143,172],"blockage":[148],"presence":[151],"further":[152],"induced":[153],"\"protective":[155],"immune":[156],"phenotype\"":[157],"boosted":[160],"T-helper":[161],"(Th),":[162],"temporary":[163],"memory":[164],"(TM),":[165],"effector":[167],"(E)":[168],"sub-population.":[169],"proof-of-concept":[171],"dual-action":[177],"mechanism":[178],"could":[179],"provide":[180],"multifactorial":[182],"solution":[183],"toward":[184],"achieving":[185],"\"functional":[187],"cure.\"":[188]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2022-06-13T00:00:00"}